Your browser doesn't support javascript.
loading
Identification of galectin-3 as a possible antibody target for secondary progressive multiple sclerosis.
Nishihara, Hideaki; Shimizu, Fumitaka; Kitagawa, Takao; Yamanaka, Nanami; Akada, Junko; Kuramitsu, Yasuhiro; Sano, Yasuteru; Takeshita, Yukio; Maeda, Toshihiko; Abe, Masaaki; Koga, Michiaki; Nakamura, Kazuyuki; Kanda, Takashi.
Afiliación
  • Nishihara H; Department of Neurology and Clinical Neuroscience, Graduate School of Medicine, Yamaguchi University, Ube, Japan.
  • Shimizu F; Department of Neurology and Clinical Neuroscience, Graduate School of Medicine, Yamaguchi University, Ube, Japan/Biogen, Cambridge, MA, USA.
  • Kitagawa T; Department of Biochemistry and Functional Proteomics, Graduate School of Medicine, Yamaguchi University, Ube, Japan.
  • Yamanaka N; Department of Neurology and Clinical Neuroscience, Graduate School of Medicine, Yamaguchi University, Ube, Japan.
  • Akada J; Department of Biochemistry and Functional Proteomics, Graduate School of Medicine, Yamaguchi University, Ube, Japan/Department of Environmental and Preventive Medicine, Faculty of Medicine, Oita University, Yufu, Japan.
  • Kuramitsu Y; Department of Biochemistry and Functional Proteomics, Graduate School of Medicine, Yamaguchi University, Ube, Japan.
  • Sano Y; Department of Neurology and Clinical Neuroscience, Graduate School of Medicine, Yamaguchi University, Ube, Japan.
  • Takeshita Y; Department of Neurology and Clinical Neuroscience, Graduate School of Medicine, Yamaguchi University, Ube, Japan.
  • Maeda T; Department of Neurology and Clinical Neuroscience, Graduate School of Medicine, Yamaguchi University, Ube, Japan.
  • Abe M; Department of Neurology and Clinical Neuroscience, Graduate School of Medicine, Yamaguchi University, Ube, Japan.
  • Koga M; Department of Neurology and Clinical Neuroscience, Graduate School of Medicine, Yamaguchi University, Ube, Japan.
  • Nakamura K; Department of Biochemistry and Functional Proteomics, Graduate School of Medicine, Yamaguchi University, Ube, Japan; Centre of Clinical Laboratories in Tokuyama Medical Association Hospital, Shunan, Japan.
  • Kanda T; Department of Neurology and Clinical Neuroscience, Graduate School of Medicine, Yamaguchi University, Ube, Japan.
Mult Scler ; 23(3): 382-394, 2017 Mar.
Article en En | MEDLINE | ID: mdl-27339072
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Barrera Hematoencefálica / Esclerosis Múltiple Crónica Progresiva / Galectina 3 / Células Endoteliales / Anticuerpos Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Mult Scler Asunto de la revista: NEUROLOGIA Año: 2017 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Barrera Hematoencefálica / Esclerosis Múltiple Crónica Progresiva / Galectina 3 / Células Endoteliales / Anticuerpos Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Mult Scler Asunto de la revista: NEUROLOGIA Año: 2017 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido